Traws Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Traws Pharma has a total shareholder equity of $6.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $18.7M and $12.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$16.89m |
| Equity | US$6.10m |
| Total liabilities | US$12.59m |
| Total assets | US$18.69m |
Recent financial health updates
We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate
Mar 09
Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation
Apr 22Recent updates
We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate
Mar 09Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation
Apr 22Onconova Therapeutics (NASDAQ:ONTX) Is In A Good Position To Deliver On Growth Plans
Jul 27Will Onconova Therapeutics (NASDAQ:ONTX) Spend Its Cash Wisely?
Mar 21Companies Like Onconova Therapeutics (NASDAQ:ONTX) Are In A Position To Invest In Growth
Dec 06Onconova Therapeutics names Mark Gelder as chief medical officer
Jun 01Onconova Therapeutics announces $8.7M registered direct offering
Jan 07Onconova cleared to start Phase 1 trial for cancer therapy
Dec 24Onconova Therapeutics EPS in-line, misses on revenue
Nov 12Financial Position Analysis
Short Term Liabilities: TRAW's short term assets ($18.7M) exceed its short term liabilities ($9.9M).
Long Term Liabilities: TRAW's short term assets ($18.7M) exceed its long term liabilities ($2.7M).
Debt to Equity History and Analysis
Debt Level: TRAW is debt free.
Reducing Debt: TRAW has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TRAW has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TRAW has less than a year of cash runway if free cash flow continues to grow at historical rates of 4.8% each year.